Do low albumin and total protein reflect low protein intake or malabsorption, while normal liver enzymes make acute liver-cell injury less likely?

Nutritional biomarkers and protein reserves

• Inadequate dietary protein or malabsorption: Insufficient intake of protein or impaired gastrointestinal digestion and absorption (such as in exocrine pancreatic insufficiency) prevents the uptake of essential amino acids, depleting the body's visceral protein stores. Chronic, severe malnutrition eventually manifests as decreased serum albumin and total protein levels.
• Inflammatory confounding: Serum albumin has a relatively long half-life of approximately 20 days and is a negative acute-phase reactant. During systemic inflammation, cytokines suppress albumin gene expression in the liver and increase microvascular permeability, causing albumin to escape into the interstitial space. Consequently, decreased serum albumin and total protein levels are heavily confounded by inflammation, infection, and hydration status, making them poor primary diagnostic measures for nutritional status alone.

Assessing hepatocellular injury

• Indications of acute necrosis: Alanine transaminase (ALT) and aspartate transaminase (AST) are sensitive intracellular enzymes. Normal serum levels of these transaminases indicate that acute, high-grade hepatocyte necrosis or active, severe membrane leakage is highly unlikely.
• Limitations in chronic pathology: Normal liver enzymes do not rule out chronic or progressive liver injury. Because transaminases reflect active cell death rather than cumulative fibrosis, a substantial percentage of patients with metabolic dysfunction-associated steatotic liver disease (MASLD), chronic hepatitis C, or advanced cirrhosis present with completely normal ALT and AST levels.

Bottom line

Inadequate protein intake or malabsorption leads to depleted protein reserves, which can contribute to low serum albumin and total protein, though these markers are highly confounded by inflammation. Normal liver enzymes make active, acute primary liver-cell injury unlikely, but they cannot rule out chronic, silent, or progressive liver pathology.